Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study

Patients with low-to-normal body mass index (BMI; 

Saved in:
Bibliographic Details
Published in:Cardiovascular diabetology 2024-10, Vol.23 (1), p.372-10, Article 372
Main Authors: Mori, Yuichiro, Komura, Toshiaki, Adomi, Motohiko, Yagi, Ryuichiro, Fukuma, Shingo, Kondo, Naoki, Yanagita, Motoko, Duru, O Kenrik, Tuttle, Katherine R, Inoue, Kosuke
Format: Article
Language:English
Subjects:
Adult
Aged
Body Mass Index
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - mortality
Cardiovascular Diseases - prevention & control
Databases, Factual
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - epidemiology
Dipeptidyl-Peptidase IV Inhibitors - adverse effects
Dipeptidyl-Peptidase IV Inhibitors - therapeutic use
Female
Heart Disease Risk Factors
Humans
Incidence
Japan - epidemiology
Male
Middle Aged
Retrospective Studies
Risk Assessment
Risk Factors
Sodium-Glucose Transporter 2 Inhibitors - adverse effects
Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
Time Factors
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with low-to-normal body mass index (BMI; 
ISSN:1475-2840
1475-2840
DOI:10.1186/s12933-024-02478-7